Dosing regimen for injectable cetirizine
US11253513B2 · kind B2 · utility
1Cited by
7References
9Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Oct 7, 2019 |
| Grant date | Feb 22, 2022 |
| Priority date | — |
| Expiry date | Nov 1, 2039 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P37/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Described herein is a method of administering injectable cetirizine or levocetirizine including intravenously injecting a mammal in need thereof with a therapeutically effective amount of an injectable cetirizine or levocetirizine composition, wherein the mammal receives a maximum daily dose of the cetirizine or levocetirizine that is no more than 15 times a maximum recommended daily clinical dose for the mammal.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.